VERU INC. Increase (Decrease) in Restricted Cash
VERU INC. (VERU) reported Increase (Decrease) in Restricted Cash of $47.59 thousand for the 9-month period ending 2013-06-30, per its 10-Q filed 2013-08-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2013-08-01
- VERU INC. increase (decrease) in restricted cash for the quarter ending 2013-06-30 was $198.00.
- VERU INC. increase (decrease) in restricted cash for the quarter ending 2013-03-31 was -$3.44K, a 2319.35% decline year-over-year.
- VERU INC. increase (decrease) in restricted cash for the quarter ending 2012-12-31 was $50.83K.
- VERU INC. increase (decrease) in restricted cash for the quarter ending 2012-09-30 was $159.00.
- VERU INC. increase (decrease) in restricted cash for fiscal 2012 was $156.00.
- VERU INC. increase (decrease) in restricted cash for fiscal 2011 was -$52.00.
- VERU INC. increase (decrease) in restricted cash for fiscal 2010 was -$100.50K.
- VERU INC. increase (decrease) in restricted cash for fiscal 2009 was -$106.80K.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2013-06-30 | $198.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | -$3.24K derived: sum of 2 quarters · filed 2013-08-01 | $47.59K 10-Q · filed 2013-08-01 | $47.74K derived: sum of 4 quarters · filed 2013-08-01 |
| 2013-03-31 | -$3.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $47.39K 10-Q · filed 2013-05-02 | $47.55K derived: sum of 3 quarters · filed 2013-05-02 | $47.44K derived: sum of 4 quarters · filed 2013-08-01 |
| 2012-12-31 | $50.83K 10-Q · filed 2013-01-30 | $50.99K derived: sum of 2 quarters · filed 2013-01-30 | $50.88K derived: sum of 3 quarters · filed 2013-08-01 | $51.03K derived: sum of 4 quarters · filed 2013-08-01 |
| 2012-09-30 | $159.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $51.00 derived: sum of 2 quarters · filed 2013-08-01 | $206.00 derived: sum of 3 quarters · filed 2013-08-01 | $156.00 10-K · filed 2012-12-04 |
| 2012-06-30 | -$108.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | $47.00 derived: sum of 2 quarters · filed 2013-08-01 | -$3.00 10-Q · filed 2013-08-01 | -$116.00 derived: sum of 4 quarters · filed 2013-08-01 |
| 2012-03-31 | $155.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $105.00 10-Q · filed 2013-05-02 | -$8.00 derived: sum of 3 quarters · filed 2013-05-02 | -$12.00 derived: sum of 4 quarters · filed 2013-05-02 |
| 2011-12-31 | -$50.00 10-Q · filed 2013-01-30 | -$163.00 derived: sum of 2 quarters · filed 2013-01-30 | -$167.00 derived: sum of 3 quarters · filed 2013-01-30 | -$4.00 derived: sum of 4 quarters · filed 2013-01-30 |
| 2011-09-30 | -$113.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | -$117.00 derived: sum of 2 quarters · filed 2012-12-04 | $46.00 derived: sum of 3 quarters · filed 2012-12-04 | -$52.00 10-K · filed 2012-12-04 |
| 2011-06-30 | -$4.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $159.00 derived: sum of 2 quarters · filed 2012-07-31 | $61.00 10-Q · filed 2012-07-31 | -$94.82K derived: sum of 4 quarters · filed 2012-12-04 |
| 2011-03-31 | $163.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-01 | $65.00 10-Q · filed 2012-05-01 | -$94.81K derived: sum of 3 quarters · filed 2012-12-04 | |
| 2010-12-31 | -$98.00 10-Q · filed 2012-01-31 | -$94.98K derived: sum of 2 quarters · filed 2012-12-04 | ||
| 2010-09-30 | -$94.88K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | -$100.50K 10-K · filed 2012-12-04 | ||
| 2010-06-30 | -$5.62K 10-Q · filed 2011-08-05 | |||
| 2009-09-30 | -$106.80K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |